Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Ito

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Hematology (Amsterdam, Netherlands)|April 29, 2025
Insights into very elderly multiple myeloma treatment from Kansai Myeloma ForumYusuke Okayama, Teruhito Takakuwa, Yuji Shimura, et al.
Ejhaem|July 18, 2022
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma ForumAya Nakaya, Hirohiko Shibayama, Eiji Nakatani, et al.
International Journal of Hematology|July 9, 2022
Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 studyYoko Edahiro, Tomoki Ito, Akihiko Gotoh, et al.
International Journal of Hematology|November 2, 2021
Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 studyYoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, et al.
Ejhaem|July 16, 2025
Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential ThrombocythemiaYoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, et al.
International Journal of Hematology|April 8, 2022
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapyChikashi Yoshida, Takeshi Kondo, Tomoki Ito, et al.
Annals of Hematology|August 21, 2024
Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysisKeiki Nagaharu, Eiko Ohya, Yoko Edahiro, et al.
Cancer Immunology, Immunotherapy : CII|May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patientsYutaka Shimazu, Junya Kanda, Yoshiyuki Onda, et al.
Annals of Hematology|July 22, 2024
Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysisKeiki Nagaharu, Eiko Ohya, Yoko Edahiro, et al.
International Journal of Hematology|October 29, 2024
Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in JapanYuka Sugimoto, Keiki Nagaharu, Eiko Ohya, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Hematology (Amsterdam, Netherlands)|April 29, 2025
Insights into very elderly multiple myeloma treatment from Kansai Myeloma ForumYusuke Okayama, Teruhito Takakuwa, Yuji Shimura, et al.
Ejhaem|July 18, 2022
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma ForumAya Nakaya, Hirohiko Shibayama, Eiji Nakatani, et al.
International Journal of Hematology|July 9, 2022
Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 studyYoko Edahiro, Tomoki Ito, Akihiko Gotoh, et al.
International Journal of Hematology|November 2, 2021
Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 studyYoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, et al.
Ejhaem|July 16, 2025
Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential ThrombocythemiaYoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, et al.
International Journal of Hematology|April 8, 2022
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapyChikashi Yoshida, Takeshi Kondo, Tomoki Ito, et al.
Annals of Hematology|August 21, 2024
Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysisKeiki Nagaharu, Eiko Ohya, Yoko Edahiro, et al.
Cancer Immunology, Immunotherapy : CII|May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patientsYutaka Shimazu, Junya Kanda, Yoshiyuki Onda, et al.
Annals of Hematology|July 22, 2024
Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysisKeiki Nagaharu, Eiko Ohya, Yoko Edahiro, et al.
International Journal of Hematology|October 29, 2024
Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in JapanYuka Sugimoto, Keiki Nagaharu, Eiko Ohya, et al.
Pageof 20